<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "c:\JATS-Publishing-1-1-MathML2-DTD\JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1">
<front>
<journal-meta>
<journal-id journal-id-type="pmc">IJBBS</journal-id>
<journal-id journal-id-type="nlm-ta">IJBBS</journal-id>
<journal-id journal-id-type="publisher-id">IJBBS</journal-id>
<journal-title-group>
<journal-title>International Journal of Bioinformatics and Biological Sciences</journal-title>
</journal-title-group>
<issn pub-type="ppub">2319-5169</issn>
<issn pub-type="epub">2321-7111</issn>
<publisher>
<publisher-name>Association of Advanced Biological Research</publisher-name>
<publisher-loc>India</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="other">IJBBS-9-016</article-id>
<doi-group>
<journal-doi>10.30954/2319-5169.1.2021.3</journal-doi>
<article-doi><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="10.30954/2319-5169.1.2021.3">10.30954/2319-5169.1.2021.3</ext-link></article-doi>
</doi-group>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Study of the Effect of Dihydrohelenalin against Apolipoprotein E for the treatment of Alzheimer&#x2019;s disease: An <italic>In silico</italic> Approach</article-title>
</title-group>
<contrib-group>
<contrib id="author-1">
<name><surname>Rana</surname>
<given-names>Khushboo</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib id="author-2">
<name><surname>Gautam</surname>
<given-names>Priyanka</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib id="author-3">
<name><surname>Khare</surname>
<given-names>Noopur</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib id="author-4">
<name><surname>Jha</surname>
<given-names>Abhimanyu Kumar</given-names>
</name>
<xref ref-type="aff" rid="aff4">4</xref>
<xref ref-type="aff" rid="aff5">5</xref>
<xref ref-type="corresp" rid="cor001"/>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label>Student, <deptname>Department of Biotechnology</deptname>, Faculty of Life Sciences, <instname>Institute of Applied Medicines and Research</instname>, <instcity>Ghaziabad</instcity>, <inststate>Uttar Pradesh</inststate>, <instcountry>India</instcountry></aff>
<aff id="aff2"><label>2</label>Research Scholar, <deptname>Department of Biotechnology</deptname>, <instname>Institute of Technology and Management</instname>, Meerut, Uttar Pradesh, Affiliated to Dr. A.P.J. Abdul Kalam Technical University, <instcity>Lucknow</instcity>, <inststate>Uttar Pradesh</inststate>, <instcountry>India</instcountry></aff>
<aff id="aff3"><label>3</label>Student, <deptname>Department of Biotechnology</deptname>, <instname>Shri Ramswaroop Memorial University</instname>, <instcity>Barabanki</instcity>, <inststate>Uttar Pradesh</inststate>, <instcountry>India</instcountry></aff>
<aff id="aff4"><label>4</label>Associate Professor, <deptname>Department of Biotechnology</deptname>, Faculty of Life Sciences, <instname>Institute of Applied Medicines and Research</instname>, <instcity>Ghaziabad</instcity>, <inststate>Uttar Pradesh</inststate>, <instcountry>India</instcountry></aff>
<aff id="aff5"><label>5</label>Associate Professor, <deptname>Department of Biotechnology</deptname>, <instname>Institute of Technology and Management</instname>, Meerut, Uttar Pradesh, Affiliated to Dr. A.P.J. Abdul Kalam Technical University, <instcity>Lucknow</instcity>, <inststate>Uttar Pradesh</inststate>, <instcountry>India</instcountry></aff>
<author-notes>
<corresp id="cor001">*Corresponding author: Abhimanyu Kumar Jha, Department of Biotechnology, Faculty of Life Sciences, Institute of Applied Medicines and Research, Ghaziabad, Uttar Pradesh, India. E-mail: <email>abhimanyujha630@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>06</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub" date-type="pub" iso-8601-date="2021-01-04">
<day>23</day>
<month>06</month>
<year iso-8601-date="2021">2021</year>
</pub-date>
<volume>9</volume>
<issue>1</issue>
<fpage>16</fpage>
<lpage>22</lpage>
<history>
<date date-type="received" iso-8601-date="2021-03-12">
<day>08</day>
<month>03</month>
<year>2021</year>
</date>
<date date-type="rev-recd" iso-8601-date="2021-03-12">
<day>09</day>
<month>03</month>
<year>2021</year>
</date>
<date date-type="accepted" iso-8601-date="2021-05-07">
<day>18</day>
<month>05</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>&#x00A9; Association of Advanced Biological Research</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Association of Advanced Biological Research</copyright-holder>
</permissions>
<self-uri content-type="pdf" xlink:href="IJBBS-9-016.pdf"></self-uri>
<abstract>
<title>ABSTRACT</title>
<p>Alzheimer&#x2019;s disease (AD) is also known as neurodegenerative disease, which normally causes 60&#x2013;70&#x0025; of dementia. There are many genetic and environmental risk factors associated with its development. The strongest genetic risk factor occurs by apolipoprotein E (apoE). Another type of risk factor may include high blood pressure, clinical depression, and head injury. In 2015, there were 29.8 million people affected worldwide by AD. Women get at risk more often than men. The present study was to inhibit the expression of apoE by dihydrohelenalin (DH) with the help molecular docking for the treatment of AD. The molecular docking method was performed after the screening of molecules and selecting the ligands which can inhibit and target the proteins. apoE (Protein Data Bank [PDB] ID 1GS9) protein was targeted through seven ligands compound and the best ligand was selected for further molecular docking and modeling tools. Thus, screening showed DH (with the binding affinity of &#x2212;5.3 kcal/mol) as a ligand molecule that may inhibit apoE. DH has the highest binding properties. Thus, it may be used further used for the treatment of AD. The DH may be the beneficial drug for the treatments of AD in future studies after <italic>in vitro</italic> and <italic>in vivo</italic> studies.</p>
</abstract>
<kwd-group>
<kwd>Alzheimer&#x2019;s disease</kwd>
<kwd>Apolipoprotein E</kwd>
<kwd>AutoDock Vina</kwd>
<kwd>Ligand</kwd>
<kwd>Molecular docking</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="5"/>
<ref-count count="31"/>
<page-count count="7"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>INTRODUCTION</title>
<p>Alzheimer&#x2019;s disease (AD) is a serious pathological disease defined through the accumulation of intracellular neurofibrillary tangles and extensive loss of neuronal and plaques by extracellular amyloid in the brain. According to clinical Phase, the sysmptoms is marked in AD by neurotransmitter loss, neuron inflammation, synaptic loss, and selective neuronal death (Holtzman <italic>et al.</italic>, 2011). It was first described in 1906. Since the 1980s, AD was considered the serious cause of dementia in older adults. Therefore, in 1984, beta-amyloid protein was identified in the blood vessels of Down syndrome patients and AD suggested that the 21<sup>st</sup> chromosome presents like an extra copy in people with Down syndrome. AD was classified into three types according to their genetic change in the brain such as late-onset type, early-onset type, and familial type.</p>
<p>Apolipoprotein is a type of protein that binds lipids to form lipoproteins and transports the lipids in lymph, blood, and cerebrospinal fluid (Samy, 2014). There are several classes of apolipoprotein such as &#x2013; A, B, C, D, E, F, H, L, and M, which play specific function for their region. The major risk factor is influencing a sporadic AD in the form of genotype for apolipoprotein E (apoE) (Blennow <italic>et al.</italic>, 2006). The humans were showing polymorphism effect in the apoE gene with three different alleles (E2, E3, and E4), based on six different phenotypes (E2/2, E2/3, E2/4, E3/3, and E4/4) (Ashford <italic>et al.</italic>, 2004).</p>
<p>The apoE was predominantly secreted through microglia and astrocytes (Pitas <italic>et al.</italic>, 1987; Uchihara <italic>et al.</italic>, 1995) in the brain while neurons should produce it (Aoki <italic>et al.</italic>, 2003; Xu <italic>et al.</italic>, 1999). The apoE is affects lipid-binding properties and three dimensional between isoforms (Mahley <italic>et al.</italic>, 1996). The apoE is playing a key role in the uptake and transport of cholesterol with lipoprotein receptors, including the low-density lipoprotein (LDL) receptors at high-affinity interaction (Wilson <italic>et al.</italic>, 1991).</p>
<p>Molecular docking is used to screen the drug based on its structure and drug designing. The small molecules that interacted with the target protein were analyzed through docking. The molecular docking method is based on structural-based drug designing with ligand-binding sites in a protein of three-dimensional structures (Ferreira <italic>et al.</italic>, 2015). According to computational approaches, docking helps with screening the compound sets which depend on free binding energies and hypotheses the molecules can inhibit their target (Abheepsa Mishra and Satyahari Dey, 2019). The comparison of docking molecules of proteins was an alternative to the drug-like properties from the initial molecule, which can allow to calculate their recorded values. In the present study, the natural compounds from different plant sources such as oleanolic acid, dihydrohelenalin (DH), harmol, vasicinone, vasicine, chavicol, and myrcene were selected against apoE for the treatment of ADs with the help of molecular docking.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>MATERIALS AND METHODS</title>
<sec id="s2-1">
<title>Identification of Protein by UniProt</title>
<p>apoE is an associated protein with lipid particles and is mainly involved in lipoprotein-mediated lipid transport between organs through the interstitial fluids and plasma. It binds a cellular receptor including the LDL receptor and LDL receptor-related proteins have subclasses LRP1, LRP2, and LRP8 with low-density receptor/VLDVLR. They mediate the cellular uptake and transport of apoE containing lipoprotein particles. The structure of apoE (PDB ID 1GS9) was obtained by PDB https://www.rcsb.org/(Berman, 2000).</p>
</sec>
<sec id="s2-2">
<title>Retrieval of Ligands by PubChem</title>
<p>Oleanolic acid, DH, harmol, vasicinone, vasicine, chavicol, and myrcene were used for the study of docking from the literature. Oleanolic acid is a pentacyclic triterpenoid, commonly found in olive oil and also present in different plant species. It is inhibited of the cellular inflammatory process, known to induce Phase 2 xenobiotic biotransformation enzymes. The highest amounts were found in edible parts of jujube (<italic>Ziziphus jujuba</italic> Mill.), which is commonly consumed by fruit in South Asia and China (Guo <italic>et al.</italic>, 2015). It is a derivative to induced both extrinsic and intrinsic apoptosis from multiple signaling pathways.</p>
<p>DH is found in Arnica Montana. The DH esters have low response factors against ultraviolet detection. DH is responsible for the activity of anti-inflammatory properties in <italic>Arnica montana</italic> L. (Asteraceae) and their extracts have short-chain esters of sesquiterpene lactones DH. DH is inhibited collagen-induced platelet aggregation, 5-hydroxytryptamine secretion, and thromboxane formation with a concentration-dependent manner at 3&#x2013;300 mm. While DH is reduced, the number of acid-soluble sulfhydryl groups that is present in platelets increase up to 78&#x0025; than their anti-aggregatory concentrations.</p>
<p>Harmol was a chemical compound, which classified as &#x03B2;-carboline alkaloids (Abe and Kokuba, 2013). It is manufactured by harmalol, harman, harmaline, and harmine, which are related to hallucinogenic alkaloids. Harmine was first identified from the seeds of Syrian rue (<italic>Peganum harmala</italic>), found in a wild desert shrub of Central Asia, Syria, and the Middle East. Other related alkaloids are derived from the bark and stems of ayahuasca (<italic>Banisteriopsis caapi</italic>). It was found <italic>in vivo</italic> in humans from O-demethylation of harmine (Morales-Garcia <italic>et al.</italic>, 2017). The &#x03B2;-carboline alkaloids were naturally occurring plant substances, known as a wide spectrum of psychopharmacological, neuropharmacological, and antitumor effects.</p>
<p>Vasicinone is a form of quinazoline alkaloid that shows bronchodilatory activity <italic>in vitro</italic> and <italic>in vivo</italic> (Amin and Mehta, 1959; Mehta <italic>et al.</italic>, 1963). It was showing anti-anaphylactic action which presents with <italic>Peganum harmala</italic> (Rajani <italic>et al.</italic>, 2008). Vasicinone has used the leaf extracts of <italic>Adhatoda vasica</italic> Nees, was reported that vasicinone is the major metabolite of vasicine (Amin and Mehta, 1959). They show apoptotic properties in a cell-specific manner (Qazi <italic>et al.</italic>, 2014) and inhibited the PI3K/Akt/FoxO3a pathways <italic>in vivo</italic> and <italic>in vitro</italic>.</p>
<p>Vasicine (peganine) is found in <italic>Justicia adhatoda</italic> and it&#x2019;s a quinazoline alkaloid. In addition, vasicine is present in <italic>Peganum harmala</italic> (Moloudizargari <italic>et al.</italic>, 2013). Their chemical formula is C<sub>11</sub>H<sub>12</sub>H<sub>2</sub>O and compared to theophylline both <italic>in vivo</italic> and <italic>in vitro</italic> (Nepali <italic>et al.</italic>, 2012). They also have combination studies with their combination ratio (1:1) with bronchodilatory activity <italic>in vivo</italic> and <italic>in vitro</italic>. The alkaloids are used for respiratory stimulants (Avula <italic>et al.</italic>, 2008). Vasicine is considered to have a uterine stimulant effect (Rajani <italic>et al.</italic>, 2008).</p>
<p>Chavicol is a type of organic compound and a natural phenylpropene, which considers the benzene ring chemical structure with hydroxyl group and a propenyl group substitute. They have been found colorless liquid property with terpenes in betel oil. It is miscible with chloroform, alcohol, and ether. Their dimerization gives neolignan magnolol. It is used in odorant in perfumery and as a flavor that presents many essential oils including gardenia and anise (Lide, 2005).</p>
<p>Myrcene is also known as &#x03B2;-myrcene. Their chemical formula is C10H16 with 0.794 g/cm<sup>3</sup> density. It is a type of alkene natural hydrocarbon, which may be classified due to monoterpene. Monoterpene is an isoprenoid precursor and is found in the composition of essential oil of different plants such as hops, bay, and cannabis (Behr and Johnen, 2009; Chyau <italic>et al.</italic>, 1996). &#x1FB3;-Myrcene consists of isomer 2-methyl-6-methylene-1, 7-octadiene, which not present in nature (Behr and Johnen, 2009). It is described from pyrolysis (400&#x00B0;C) of &#x03B2;-pinene, which is obtained by turpentine (Behr and Johnen, 2009) and directly from plants (Eggersdorfer, 2005).</p>
<p>All ligand molecules were selected by the natural compound of several plants. All these ligand molecules were retrieved in 3D structure in &#x201C;.sdf&#x201D; format from PubChem (https://pubchem.ncbi.nlm.nih.gov/) (Graff and Mansuy, 2008) and also. All ligands structures were downloaded and can convert into a &#x201C;.pdb&#x201D; file through an online server (https://cactus.nci.nih.gov/translate/) through SMILES Translator (Berman <italic>et al.</italic>, 2000). The converting &#x201C;.pdb&#x201D; files were downloaded into &#x201C;.pdb&#x201D; format and run files into different tools and software&#x2019;s (https://pubchem.ncbi.nlm.nih.gov/).</p>
</sec>
<sec id="s2-3">
<title>Protein Preparation</title>
<p>In protein preparation, the missing atoms in the incomplete residues are attached and the protein molecule is prepared by removing water molecules and active sites of extra ligands are also removed. The alternative conformations (disorder) are deleted along with modelling the missing loop regions in standardizing atom names (Kim <italic>et al.</italic>, 2015). The docked molecule structure can be view at the time of software. This software was used for the protein molecule loaded in the graphical windows and under analyzed the view option of hierarchy. Those water molecules that were attached with ligand molecules are deleted through selecting atoms and the protein crystal structure will be saved in a.pdb format file. This.pdb format file of protein was used for docking.</p>
</sec>
<sec id="s2-4">
<title>Preparation of Grid Parameters and Virtual Screening by PYRX</title>
<p>Grid maps were used to generate and spacing by 0.375 &#x00C5; adjusted and cannot have ligand-binding properties. The grid dimension was adjusted to 40 &#x00D7; 40 &#x00D7; 40 points. AutoDock Vina was used to interacting with docking maps and values were calculated by AutoGrid. For each and every interaction between ligand atom and receptor, the entire binding energy of the site is calculated that represented in the grid. The selected protein of interaction energy was assigned at every one point of the grid and calculated their ligand affinity.</p>
<p>PyRx software was used for the future virtual screening of the ligands. This software was used to demonstrate the ligands with minimum binding energy with protein target through the virtual screening. Those ligands were found their minimum binding energy with a screening of drug likeliness property analysis. The protein molecule was loaded in the PyRx window and was converted the file from the.pdb format file to.pdbqt format file and then ligands were saved in.sdf format file folder. The minimum energy of ligands was converting the.sdf file to &#x201C;.pdbqt&#x201D; format. The results were analyzed based on their binding affinity.</p>
</sec>
<sec id="s2-5">
<title>Drug Likeliness Property Analysis by SwissADME</title>
<p>Drug likeliness property was analyzed through an online server through SwissADME. The natural compounds were used for final molecular docking studies by screening those ligands which having drug-like properties. Canonical SMILE text ligands of notations were copied by PubChem and run on the SwissADME online web server (Wang <italic>et al.</italic>, 2016). Ligands were selected by Lipinski&#x2019;s rule of five. Lipinski rule of five has the following points:</p>
<p>
<list list-type="order">
<list-item>
<p>Molecular mass is &#x003C;500 Da</p>
</list-item>
<list-item>
<p>Hydrogen bond donors only less than 5 (&#x003C;5)</p>
</list-item>
<list-item>
<p>High lipophilicity can be expressed as LogP &#x003C;5</p>
</list-item>
<list-item>
<p>Hydrogen bond acceptors only allow less than 10 (&#x003C; 10)</p>
</list-item>
<list-item>
<p>One violation value only considered.</p>
</list-item>
</list>
</p>
<p>The ligands were based on the Lipinski rule of five and used for final docking further through AutoDock Vina.</p>
</sec>
<sec id="s2-6">
<title>Molecular Docking Between Receptor Protein and Selected Compound by MGL Tools</title>
<p>The protein target file of.pdb format was loaded on AutoDock Vina graphical windows. The protein target file of.pdb format was prepared through docking by deleting of water molecules, adding hydrogen polar atoms, and adding Kollman charges of the protein molecule and protein file was further save in &#x201C;.pdbqt&#x201D; format file, and compounds were converting their.pdb format file into &#x201C;. pdbqt&#x201D; file format. Selected the grid box was docked region. Using Autodock result in command prompt and results were analyzed (https://cactus.nci.nih.gov/translate/.). Molecular docking was analyzed out between the target protein molecule and ligand.</p>
</sec>
<sec id="s2-7">
<title>Structure Visualization Using PYMOL</title>
<p>Structure visualization was performed through the tool PyMOL 2.4. PyMOL 2.4 is a software and freely available tool in a website server. Selected the protein molecule from the &#x201C;.pdbqt&#x201D; format file and was uploading in their graphical showing screen of PyMOL 2.4 tool and imported the output &#x201C;.pdbqt&#x201D; file in the software. The docking structure of PyMOL 2.4 was visualized through the screen and may select the option molecule was converted into &#x201C;molecular surface.&#x201D; PyMol software was used for better visualization of protein and ligand interaction in the molecular surface. After AutoDock Vina, the output file was automatically saved in the selected folder with the name output.pdbqt file. This protein.pdbqt files with output.pdbqt files were loaded on their graphical screen of PyMol. The interaction between the protein and ligand was visualized and analyzed.</p>
</sec>
</sec>
<sec id="s3" sec-type="results|discussion">
<title>RESULTS AND DISCUSSION</title>
<p>The APOE crystal structure was retrieved by PDB in.pdb format, as shown in <xref ref-type="fig" rid="fig1">Figure 1</xref> and <xref ref-type="fig" rid="fig2">Figure 2</xref>. APOE was classified by lipid-binding protein, the protein resolution value consists of 1.70&#x00C5;, R-value work consists of 0.218, R-value free consists of 0.247, and R-value was 0.219 by following X-ray diffraction method. The protein stability was retrieved from the online database PubChem. The structures of oleanolic acid, DH, harmol, vasicinone, vasicine, chavicol, and myrcene were downloaded in 3D format structure &#x201C;.sdf&#x201D; file format which shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>a-g and <xref ref-type="fig" rid="fig4">Figure 4</xref>. Finally, the protein structure was downloaded and converted into a &#x201C;.pdb&#x201D; file format.</p>
<fig id="fig1">
<label>Figure 1</label><caption>
<p>The structure of human apolipoprotein E [1GS9]</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IJBBS-9-016-f001.tif"/>
</fig>
<fig id="fig2">
<label>Figure 2</label><caption>
<p>Biological assembly structure of protein</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IJBBS-9-016-f002.tif"/>
</fig>
<fig id="fig3">
<label>Figure 3</label><caption>
<p>Structure of (a) oleanolic acid, (b) dihydrohelenalin, (c) harmol, (d) vasicinone, (e) vasicine, (f) chavicol, and (g) myrcene</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IJBBS-9-016-f003.tif"/>
</fig>
<fig id="fig4">
<label>Figure 4</label><caption>
<p>Three-dimensional crystalline structure of ligands with their CID, MW, and MF</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IJBBS-9-016-f004.tif"/>
</fig>
<p>
<list list-type="bullet">
<list-item>
<p>Protein name : Apolipoprotein E</p>
</list-item>
<list-item>
<p>Gene : APOE</p>
</list-item>
<list-item>
<p>Protein database No : 1GS9</p>
</list-item>
<list-item>
<p>Classification : Lipid-binding protein</p>
</list-item>
<list-item>
<p>Organism (s) : Homo sapiens (human)</p>
</list-item>
<list-item>
<p>Expression system : Escherichia Coli BL21</p>
</list-item>
<list-item>
<p>Mutation : Yes</p>
</list-item>
<list-item>
<p>Sequence length : 165</p>
</list-item>
</list>
</p>
<p>All these seven oleanolic acid, DH, harmol, vasicinone, vasicine, chavicol, and myrcene ligands were used for virtual screening by PyRx software and result, as shown in <xref ref-type="table" rid="T1">Table 1</xref>. The DH retrieved the binding affinity &#x2212;5.3 Kcal/mol, and having C<sub>15</sub>H<sub>2</sub>OO<sub>4</sub> molecular formula with root mean square deviation (RMSD) lower bound value was 0 and upper bound value was 0 in Mode 0 and if we considered the value in mode 1, then binding affinity was retrieved &#x2212;5.2 Kcal/mol with RMSD lower bound value was 22.305 and having upper bound value was 24.29 in above table.</p>
<table-wrap id="T1">
<label>Table 1</label><caption>
<p>Interaction between ligands and proteins through PyRx</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IJBBS-9-016-f005.tif"/>
</table-wrap>
<p>In the PyRx results, among all the ligand molecules, DH and oleanolic acid showed minimum binding energy. The screening molecules of oleanolic acid, DH, harmol, vasicinone, vasicine, chavicol, and myrcene were analyzed for drug likeliness property analysis from SwissADME. The screening of all seven ligands was analyzed through the online web server SwissADME. Further, these seven ligands were considered through their qualifying Lipinski&#x2019;s rule of five screened. Oleanolic acid has found minimum binding energy with its specific protein molecule but they have one violation. On the other hand, DH also having minimum binding energy with ligands and protein molecule but they have 0 violation; it was good to qualify the rule of qualifying Lipinski&#x2019;s rule of five.</p>
<p>The DH ligand was screened by docking of protein target through AutoDock Vina. AutoDock Vina was software; ligand was retrieved minimum binding energy. DH was retrieved best binding ligand affinity against protein target by AutoDock Vina, as shown in <xref ref-type="table" rid="T4">Table 4</xref>.</p>
<table-wrap id="T2">
<label>Table 2</label><caption>
<p>Binding energies of different compounds with CID number</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IJBBS-9-016-f006.tif"/>
</table-wrap>
<table-wrap id="T3">
<label>Table 3</label><caption>
<p>Result analyzed by drug likeliness property analysis</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IJBBS-9-016-f007.tif"/>
</table-wrap>
<table-wrap id="T4">
<label>Table 4</label><caption>
<p>Comparing result through PyRx and SwissADME</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IJBBS-9-016-f008.tif"/>
</table-wrap>
<table-wrap id="T5">
<label>Table 5</label><caption>
<p>AutoDock Vina result</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IJBBS-9-016-f009.tif"/>
</table-wrap>
<p>DH was having a very strong type of binding affinity and targets their specific region. The interaction between target proteins through ligand based on visualized PyMOL software in <xref ref-type="fig" rid="fig5">Figure 5</xref>. DH was an inhibitor that forms a drug for controlling AD by <italic>in silico</italic> study, Thus, this drug is very effective for the treatment of AD in future prospects.</p>
<fig id="fig5">
<label>Figure 5</label><caption>
<p>Interaction of apolipoprotein E protein within dihydrohelenalin ligand through PyMOL visualizer</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IJBBS-9-016-f010.tif"/>
</fig>
</sec>
<sec id="s4" sec-type="conclusion">
<title>CONCLUSION</title>
<p>The crystalline structure of protein APOE was docked by molecular docking software. Docking studies of DH were showing their strong affinity toward AD protein target. According to an <italic>in silico</italic> study, DH may act as an inhibitor which forms a drug for controlling of AD and also can be used for the treatment of AD.</p>
</sec>
<sec id="s5">
<title>CONFLICTS OF INTEREST STATEMENT</title>
<p>The authors declare that there are no conflicts of interest.</p>
</sec>
</body>
<back>
<ack>
<title>ACKNOWLEDGMENTS</title>
<p>The authors acknowledge the help provided by the Department of Biotechnology, Faculty of Life Sciences, Institute of Applied Medicines and Research, Ghaziabad, Uttar Pradesh, India.</p>
</ack>
<ref-list>
<title>REFERENCES</title>
<ref id="bib001">
<label>1</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Abe</surname>
<given-names>A</given-names>
</string-name>
<string-name>
<surname>Kokuba</surname>
<given-names>H</given-names>
</string-name>
</person-group>
<article-title>Harmol induces autophagy and subsequent apoptosis in U251MG human glioma cells through the downregulation of survivin</article-title>
<source>Oncol. Rep</source>
<year>2013</year>
<volume>29</volume>
<fpage>1333</fpage>
<lpage>1342</lpage>
</mixed-citation>
</ref>
<ref id="bib002">
<label>2</label>
<mixed-citation publication-type="journal">
<collab>Abheepsa Mishra, and SatyahariDey;Molecular Docking Studies of a Cyclic Octapeptide-Cyclosaplin from Sandalwood</collab>
<source>Biomolecules</source>
<year>2019</year>
<volume>9</volume>
<fpage>740</fpage>
</mixed-citation>
</ref>
<ref id="bib003">
<label>3</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Amin</surname>
<given-names>A.H</given-names>
</string-name>
<string-name>
<surname>Mehta</surname>
<given-names>D.R</given-names>
</string-name>
</person-group>
<article-title>A bronchodilator alkaloid (vasicinone) from <italic>Adhatoda vasica</italic> Nees</article-title>
<source>Nature</source>
<year>1959</year>
<volume>184</volume>
<fpage>1317</fpage>
<lpage>1317</lpage>
</mixed-citation>
</ref>
<ref id="bib004">
<label>4</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Aoki</surname>
<given-names>K</given-names>
</string-name>
<string-name>
<surname>Uchihara</surname>
<given-names>T</given-names>
</string-name>
<string-name>
<surname>Sanjo</surname>
<given-names>N</given-names>
</string-name>
<string-name>
<surname>Nakamura</surname>
<given-names>A</given-names>
</string-name>
<string-name>
<surname>Ikeda</surname>
<given-names>K</given-names>
</string-name>
<string-name>
<surname>Tsuchiya</surname>
<given-names>K</given-names>
</string-name>
<string-name>
<surname>Wakayama</surname>
<given-names>Y</given-names>
</string-name>
</person-group>
<article-title>Increased expression of neuronal apolipoprotein E in human brain with cerebral infarction</article-title>
<source>Stroke</source>
<year>2003</year>
<volume>34</volume>
<fpage>875</fpage>
<lpage>880</lpage>
</mixed-citation>
</ref>
<ref id="bib005">
<label>5</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ashford</surname>
<given-names>J.W</given-names>
</string-name>
</person-group>
<article-title>APOE genotype effects on Alzheimer&#x0027;s disease onset and epidemiology</article-title>
<source>J. Mol. Neurosci</source>
<year>2004</year>
<volume>23</volume>
<fpage>157</fpage>
<lpage>165</lpage>
</mixed-citation>
</ref>
<ref id="bib006">
<label>6</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Avula</surname>
<given-names>B</given-names>
</string-name>
<string-name>
<surname>Begum</surname>
<given-names>S</given-names>
</string-name>
<string-name>
<surname>Ahmed</surname>
<given-names>S</given-names>
</string-name>
<string-name>
<surname>Choudhary</surname>
<given-names>M.I</given-names>
</string-name>
<string-name>
<surname>Khan</surname>
<given-names>I.A</given-names>
</string-name>
</person-group>
<article-title>Quantitative determination of vasicine and vasicinone in <italic>Adhatoda vasica</italic> by high performance capillary electrophoresis</article-title>
<source>Pharmazie</source>
<year>2008</year>
<volume>63</volume>
<fpage>20</fpage>
<lpage>22</lpage>
</mixed-citation>
</ref>
<ref id="bib007">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Behr</surname>
<given-names>A</given-names>
</string-name>
<string-name>
<surname>Johnen</surname>
<given-names>L</given-names>
</string-name>
</person-group>
<article-title>Myrcene as a natural base chemical in sustainable chemistry:A critical review</article-title>
<source>Chem. Sustain. Chem</source>
<year>2009</year>
<volume>2</volume>
<fpage>1072</fpage>
<lpage>1095</lpage>
</mixed-citation>
</ref>
<ref id="bib008">
<label>8</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Berman</surname>
<given-names>H.M</given-names>
</string-name>
</person-group>
<article-title>The Protein Data Bank</article-title>
<source>Nucleic Acids Res</source>
<year>2000</year>
<volume>28</volume>
<fpage>235</fpage>
<lpage>242</lpage>
</mixed-citation>
</ref>
<ref id="bib009">
<label>9</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Berman</surname>
<given-names>H.M</given-names>
</string-name>
<string-name>
<surname>Henrick</surname>
<given-names>K</given-names>
</string-name>
<string-name>
<surname>Nakamura</surname>
<given-names>H</given-names>
</string-name>
</person-group>
<article-title>Announcing the worldwide protein data bank</article-title>
<source>Nat. Struct. Biol</source>
<year>2000</year>
<volume>10</volume>
<fpage>980</fpage>
</mixed-citation>
</ref>
<ref id="bib010">
<label>10</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Blennow</surname>
<given-names>K</given-names>
</string-name>
<string-name>
<surname>De Leon</surname>
<given-names>M.J</given-names>
</string-name>
<string-name>
<surname>Zetterberg</surname>
<given-names>H</given-names>
</string-name>
</person-group>
<article-title>Alzheimer&#x0027;s disease</article-title>
<source>Lancet</source>
<year>2006</year>
<volume>368</volume>
<fpage>387</fpage>
<lpage>403</lpage>
</mixed-citation>
</ref>
<ref id="bib011">
<label>11</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Chyau</surname>
<given-names>C.C</given-names>
</string-name>
<string-name>
<surname>Mau</surname>
<given-names>J.L</given-names>
</string-name>
<string-name>
<surname>Wu</surname>
<given-names>C.M</given-names>
</string-name>
</person-group>
<year>1996</year>
<article-title>Characteristics of the steam-distilled oil and carbon dioxide extract of <italic>Zanthoxylum simulans</italic> fruits</article-title>
<source>J. Agric. Food Chem</source>
<volume>44</volume>
<fpage>1096</fpage>
<lpage>1099</lpage>
</mixed-citation>
</ref>
<ref id="bib012">
<label>12</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Eggersdorfer</surname>
<given-names>M</given-names>
</string-name>
</person-group>
<article-title>Terpenes Ullmann&#x0027;s Encyclopedia of Industrial Chemistry</article-title>
<source>Wiley-VCH, Weinheim</source>
<year>2005</year>
</mixed-citation>
</ref>
<ref id="bib013">
<label>13</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ferreira</surname>
<given-names>L</given-names>
</string-name>
<string-name>
<surname>dos Santos</surname>
<given-names>R</given-names>
</string-name>
<string-name>
<surname>Oliva</surname>
<given-names>G</given-names>
</string-name>
<string-name>
<surname>Andricopulo</surname>
<given-names>A</given-names>
</string-name>
</person-group>
<year>2015</year>
<article-title>Molecular docking and structure-based drug design strategies</article-title>
<source>Molecules</source>
<volume>20</volume>
<fpage>13384</fpage>
<lpage>13421</lpage>
</mixed-citation>
</ref>
<ref id="bib014">
<label>14</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Graff</surname>
<given-names>J</given-names>
</string-name>
<string-name>
<surname>Mansuy</surname>
<given-names>I.M</given-names>
</string-name>
</person-group>
<article-title>Epigenetic codes in cognition and behaviour</article-title>
<source>Behav. Brain Res</source>
<year>2008</year>
<volume>192</volume>
<fpage>70</fpage>
<lpage>87</lpage>
</mixed-citation>
</ref>
<ref id="bib015">
<label>15</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Guo</surname>
<given-names>S</given-names>
</string-name>
<string-name>
<surname>Duan</surname>
<given-names>J</given-names>
</string-name>
<string-name>
<surname>Qian</surname>
<given-names>D</given-names>
</string-name>
<string-name>
<surname>Tang</surname>
<given-names>Y</given-names>
</string-name>
<string-name>
<surname>Wu</surname>
<given-names>D</given-names>
</string-name>
<string-name>
<surname>Su</surname>
<given-names>S</given-names>
</string-name>
<string-name>
<surname>Wang</surname>
<given-names>H</given-names>
</string-name>
<string-name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</string-name>
</person-group>
<article-title>Content variations of triterpenic acid, nucleoside, nucleobase, and sugar in jujube (Ziziphusjujuba) fruit during ripening</article-title>
<source>Food Chem</source>
<year>2015</year>
<volume>167</volume>
<fpage>468</fpage>
<lpage>474</lpage>
</mixed-citation>
</ref>
<ref id="bib016">
<label>16</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Holtzman</surname>
<given-names>D.M</given-names>
</string-name>
<string-name>
<surname>Morris</surname>
<given-names>J.C</given-names>
</string-name>
<string-name>
<surname>Goate</surname>
<given-names>A.M</given-names>
</string-name>
</person-group>
<year>2011</year>
<article-title>Alzheimer&#x0027;s disease:The challenge of the second century</article-title>
<source>Sci. Transl. Med</source>
<volume>3</volume>
<fpage>77</fpage>
<lpage>71</lpage>
</mixed-citation>
</ref>
<ref id="bib017">
<label>17</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kim</surname>
<given-names>S</given-names>
</string-name>
<string-name>
<surname>Thiessen</surname>
<given-names>P.A</given-names>
</string-name>
<string-name>
<surname>Bolton</surname>
<given-names>E.E</given-names>
</string-name>
<string-name>
<surname>Chen</surname>
<given-names>J</given-names>
</string-name>
<string-name>
<surname>Fu</surname>
<given-names>G</given-names>
</string-name>
<string-name>
<surname>Gindulyte</surname>
<given-names>A</given-names>
</string-name>
<string-name>
<surname>Bryant</surname>
<given-names>S.H</given-names>
</string-name>
</person-group>
<article-title>PubChem substance and compound databases</article-title>
<source>Nucleic Acids Res</source>
<year>2015</year>
<volume>44</volume>
<fpage>D1202</fpage>
<lpage>D1213</lpage>
</mixed-citation>
</ref>
<ref id="bib018">
<label>18</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<string-name>
<surname>Lide</surname>
<given-names>D.R</given-names>
</string-name>
</person-group>
<source>CRC Handbook of Chemistry and Physics</source>
<year>2005</year>
<edition>86th ed</edition>
<publisher-loc>Boca Raton, FL</publisher-loc>
<publisher-name>CRC Press</publisher-name>
</mixed-citation>
</ref>
<ref id="bib019">
<label>19</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Mahley</surname>
<given-names>R.W</given-names>
</string-name>
<string-name>
<surname>Nathan</surname>
<given-names>B.P</given-names>
</string-name>
<string-name>
<surname>Pitas</surname>
<given-names>R.E</given-names>
</string-name>
</person-group>
<article-title>Apolipoprotein E, structure, function, and possible roles in Alzheimer&#x0027;s disease</article-title>
<source>Ann. N. Y. Acad. Sci</source>
<year>1996</year>
<volume>777</volume>
<fpage>139</fpage>
<lpage>145</lpage>
</mixed-citation>
</ref>
<ref id="bib020">
<label>20</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Mehta</surname>
<given-names>D.R</given-names>
</string-name>
<string-name>
<surname>Naravane</surname>
<given-names>J.S</given-names>
</string-name>
<string-name>
<surname>Desai</surname>
<given-names>R.M</given-names>
</string-name>
</person-group>
<article-title>Vasicinone. A bronchodilator principle from <italic>Adhatoda vasica</italic> Nees (N. O. <italic>Acanthaceae</italic>)</article-title>
<source>J. Org. Chem</source>
<year>1963</year>
<volume>28</volume>
<fpage>445</fpage>
<lpage>448</lpage>
</mixed-citation>
</ref>
<ref id="bib021">
<label>21</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Moloudizargari</surname>
<given-names>M</given-names>
</string-name>
<string-name>
<surname>Mikaili</surname>
<given-names>P</given-names>
</string-name>
<string-name>
<surname>Aghajanshakeri</surname>
<given-names>S</given-names>
</string-name>
<string-name>
<surname>Asghari</surname>
<given-names>M.H</given-names>
</string-name>
<string-name>
<surname>Shayegh</surname>
<given-names>J</given-names>
</string-name>
</person-group>
<article-title>Pharmacological and therapeutic effects of <italic>Peganum harmala</italic> and its main alkaloids</article-title>
<source>Pharmacogn. Rev</source>
<year>2013</year>
<volume>7</volume>
<fpage>199</fpage>
<lpage>212</lpage>
</mixed-citation>
</ref>
<ref id="bib022">
<label>22</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Morales-Garcia</surname>
<given-names>J.A</given-names>
</string-name>
<string-name>
<surname>de la Fuenta Revenga</surname>
<given-names>M</given-names>
</string-name>
<string-name>
<surname>Alonso-Gil</surname>
<given-names>S</given-names>
</string-name>
<string-name>
<surname>Rodriguez-Franco</surname>
<given-names>M.I</given-names>
</string-name>
<string-name>
<surname>Feiding</surname>
<given-names>A</given-names>
</string-name>
<string-name>
<surname>Perez-Castillo</surname>
<given-names>A</given-names>
</string-name>
<string-name>
<surname>Riba</surname>
<given-names>J</given-names>
</string-name>
</person-group>
<article-title>The alkaloids of <italic>Banisteriopsis caapi</italic>, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis <italic>in vitro</italic></article-title>
<source>Sci. Rep</source>
<year>2017</year>
<volume>7</volume>
<fpage>5309</fpage>
</mixed-citation>
</ref>
<ref id="bib023">
<label>23</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Nepali</surname>
<given-names>K</given-names>
</string-name>
<string-name>
<surname>Sharma</surname>
<given-names>S</given-names>
</string-name>
<string-name>
<surname>Ojha</surname>
<given-names>R</given-names>
</string-name>
<string-name>
<surname>Dhar</surname>
<given-names>K.L</given-names>
</string-name>
</person-group>
<article-title>Vasicine and structurally related quinazolines</article-title>
<source>Med. Chem. Res</source>
<year>2012</year>
<volume>22</volume>
<fpage>1</fpage>
<lpage>15</lpage>
</mixed-citation>
</ref>
<ref id="bib024">
<label>24</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Pitas</surname>
<given-names>R.E</given-names>
</string-name>
<string-name>
<surname>Boyles</surname>
<given-names>J.K</given-names>
</string-name>
<string-name>
<surname>Lee</surname>
<given-names>S.H</given-names>
</string-name>
<string-name>
<surname>Foss</surname>
<given-names>D</given-names>
</string-name>
<string-name>
<surname>Mahley</surname>
<given-names>R.W</given-names>
</string-name>
</person-group>
<article-title>Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins</article-title>
<source>Biochim. Biophys. Acta</source>
<year>1987</year>
<volume>917</volume>
<fpage>148</fpage>
<lpage>161</lpage>
</mixed-citation>
</ref>
<ref id="bib025">
<label>25</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Qazi</surname>
<given-names>A.K</given-names>
</string-name>
<string-name>
<surname>Hussain</surname>
<given-names>A</given-names>
</string-name>
<string-name>
<surname>Aga</surname>
<given-names>M.A</given-names>
</string-name>
<string-name>
<surname>Ali</surname>
<given-names>S</given-names>
</string-name>
<string-name>
<surname>Taneja</surname>
<given-names>S.C</given-names>
</string-name>
<string-name>
<surname>Sharma</surname>
<given-names>P.R</given-names>
</string-name>
<string-name>
<surname>Saxena</surname>
<given-names>A.K</given-names>
</string-name>
<string-name>
<surname>Mondhe</surname>
<given-names>D.M</given-names>
</string-name>
<string-name>
<surname>Hamid</surname>
<given-names>A</given-names>
</string-name>
</person-group>
<article-title>Cell specific apoptosis by RLX is mediated by NFkB in human colon carcinoma HCT-116 cells</article-title>
<source>BMC Cell Biol</source>
<year>2014</year>
<volume>15</volume>
<fpage>36</fpage>
</mixed-citation>
</ref>
<ref id="bib026">
<label>26</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Rajani</surname>
<given-names>M</given-names>
</string-name>
<string-name>
<surname>Soni</surname>
<given-names>S</given-names>
</string-name>
<string-name>
<surname>Anandjiwala</surname>
<given-names>S</given-names>
</string-name>
<string-name>
<surname>Patel</surname>
<given-names>G</given-names>
</string-name>
</person-group>
<year>2008</year>
<article-title>Validation of different methods of preparation of <italic>Adhatoda vasica</italic> leaf juice by quantification of total alkaloids and vasicine</article-title>
<source>Indian J. Pharm. Sci</source>
<volume>70</volume>
<fpage>36</fpage>
<lpage>42</lpage>
</mixed-citation>
</ref>
<ref id="bib027">
<label>27</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Samy</surname>
<given-names>I.R</given-names>
</string-name>
</person-group>
<year>2014</year>
<article-title>Recent advances in physiological lipoprotein metabolism</article-title>
<source>Clin. Chem. Lab. Med</source>
<volume>52</volume>
<fpage>1695</fpage>
<lpage>1727</lpage>
</mixed-citation>
</ref>
<ref id="bib028">
<label>28</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Uchihara</surname>
<given-names>T</given-names>
</string-name>
<string-name>
<surname>Duyckaerts</surname>
<given-names>C</given-names>
</string-name>
<string-name>
<surname>He</surname>
<given-names>Y</given-names>
</string-name>
<string-name>
<surname>Kobayashi</surname>
<given-names>K</given-names>
</string-name>
<string-name>
<surname>Seilhean</surname>
<given-names>D</given-names>
</string-name>
<string-name>
<surname>Amouyel</surname>
<given-names>P</given-names>
</string-name>
<string-name>
<surname>Hauw</surname>
<given-names>J.J</given-names>
</string-name>
</person-group>
<year>1995</year>
<article-title>ApoEimmunoreactivity and microglial cells in Alzheimer&#x0027;s disease brain</article-title>
<source>Neurosci. Lett</source>
<volume>195</volume>
<fpage>5</fpage>
<lpage>8</lpage>
</mixed-citation>
</ref>
<ref id="bib029">
<label>29</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wang</surname>
<given-names>W</given-names>
</string-name>
<string-name>
<surname>Xia</surname>
<given-names>M</given-names>
</string-name>
<string-name>
<surname>Chen</surname>
<given-names>J</given-names>
</string-name>
<string-name>
<surname>Deng</surname>
<given-names>F</given-names>
</string-name>
<string-name>
<surname>Yuan</surname>
<given-names>R</given-names>
</string-name>
<string-name>
<surname>Zhang</surname>
<given-names>X</given-names>
</string-name>
<string-name>
<surname>Shen</surname>
<given-names>F</given-names>
</string-name>
</person-group>
<article-title>Data set for phylogenetic tree and RAMPAGE Ramachandran plot analysis of SODs in <italic>Gossypium raimondii</italic> and <italic>G. arboreum</italic></article-title>
<source>Data Brief</source>
<year>2016</year>
<volume>9</volume>
<fpage>345</fpage>
<lpage>348</lpage>
</mixed-citation>
</ref>
<ref id="bib030">
<label>30</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wilson</surname>
<given-names>C</given-names>
</string-name>
<string-name>
<surname>Wardell</surname>
<given-names>M.R</given-names>
</string-name>
<string-name>
<surname>Weisgraber</surname>
<given-names>K.H</given-names>
</string-name>
<string-name>
<surname>Mahley</surname>
<given-names>R.W</given-names>
</string-name>
<string-name>
<surname>Agard</surname>
<given-names>D.A</given-names>
</string-name>
</person-group>
<article-title>Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E</article-title>
<source>Science</source>
<year>1991</year>
<volume>252</volume>
<fpage>1817</fpage>
<lpage>1822</lpage>
</mixed-citation>
</ref>
<ref id="bib031">
<label>31</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Xu</surname>
<given-names>P.T</given-names>
</string-name>
<string-name>
<surname>Gilbert</surname>
<given-names>J.R</given-names>
</string-name>
<string-name>
<surname>Qiu</surname>
<given-names>H.L</given-names>
</string-name>
<string-name>
<surname>Ervin</surname>
<given-names>J</given-names>
</string-name>
<string-name>
<surname>Rothrock-Christian</surname>
<given-names>T.R</given-names>
</string-name>
<string-name>
<surname>Hulette</surname>
<given-names>C</given-names>
</string-name>
<string-name>
<surname>Schmechel</surname>
<given-names>D.E</given-names>
</string-name>
</person-group>
<year>1999</year>
<article-title>Specific regional transcription of apolipoprotein E in human brain neurons</article-title>
<source>Am. J. Pathol</source>
<volume>154</volume>
<fpage>601</fpage>
<lpage>611</lpage>
</mixed-citation>
</ref>
</ref-list>
</back>
</article>
